Sunday June 16, 2019
Home India Infosys to in...

Infosys to invest Rs 1,918 crore to develop 3 new campuses in Bengaluru

0
//
Employees queue up infront of Infosys office.

By NewsGram Staff Writer

IT giant Infosys, led by Vishal Sikka, got a green light on his proposal to set up three more campuses in Bengaluru at an investment of Rs 1,918 crore from the Karnataka government on Saturday.

Infosys has proposed to develop one new campus at Electronic City and two at Konappana Agrahara in Bengluru. The company has claimed in its proposal that it will create 27,000 new jobs from these three projects.

The IT major has also planned a Software Technology Park with an estimated cost of Rs 1,079 crore. In this project, the number of direct employment would be 15,000.

The govt. also approved the proposal from Mangalore Refinery and Petrochemicals Limited with an investment of Rs. 20,000 crore and another proposal from Biosciences with an investment of Rs. 235 crore.

Next Story

India: Boost to Biocon’s Biosimilar Business as Bengaluru Units Get European Nod

The international certification would enable the company to address the patients' needs

0
Biocon, Business, Bengaluru
In March, the European regulator (EMA) inspected the twin facilities where a range of bio-similars are manufactured. Pixabay

The European Medicines Agency (EMA) has certified the Biocon drug product and substance facilities in the city’s southern suburb for good manufacturing practice.

“We have received a certificate from EMA for the good manufacturing practice compliance by our biological drug product and substance facilities at Bengaluru,” said the city-based leading biotech firm in a statement on Saturday.

Biocon, Business, Bengaluru
The European Medicines Agency (EMA) has certified the Biocon drug product. Pixabay

In March, the European regulator (EMA) inspected the twin facilities where a range of bio-similars are manufactured. “It was a surveillance inspection of our facilities and a pre-approval inspection of our additional manufacturing line,” said the statement.

Also Read- Greenland Lost More than 2 Billion Tons of Ice, with over 40% of Country Experiencing Unusual Melting

The international certification would enable the company to address the patients’ needs in the European Union (EU) markets and enhance access to its bio-similars, said a Biocon’s spokesperson in the statement. (IANS)